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 Microvascular function is known to be altered by an oral glucose tolerance test 
 Sucrose, not glucose, better reflects habitual sugar intake 
 Consumption of 50 g of sucrose did not acutely influence microvascular function 


























Background: Sugar sweetened beverages (SSB) are a major source of dietary sugar and a public 
health concern. Glucose consumption acutely influences microvascular reactivity in healthy adults, 
possibly via oxidative stress. The purpose of this study was to observe the acute influence of a more 
relevant dose of sucrose on microvascular reactivity, and to identify whether this response is 
influenced by the amount of vitamin C typically contained in SSB. Methods: Thirteen ostensibly 
healthy adults (8 male, 5 female) performed three 1-day trials in a randomized order; the 
consumption of 300 ml water (control; CON), or 300 ml water with 50 g sucrose (SUGAR) or 50 g 
sucrose with 160 mg of vitamin C (VITC). Near infrared spectroscopy was used to determine peak 
reactive hyperaemia (PRH), the rate of desaturation (Slope 1) and reperfusion (Slope 2), and the 
total area under the reperfusion curve versus time (TRH) following 5 min of forearm cuff occlusion 
before and 30, 60, 90 and 120 min after test drink consumption. Results: SUGAR and VITC 
significantly increased the total area under the curve versus time for plasma glucose (P<0.05 for 
both). No changes in microvascular reactivity were observed between trials, although VITC increased 
Slope 1 compared to both SUGAR and CON 30 and 60 min post drink (P<0.05 for both). Conclusion: 
The consumption of a sugar load representative of commercially available SSB did not influence 
microvascular reactivity. The co-ingestion of Vitamin C also failed to influence microvascular 





























Postprandial hyperglycaemia is an independent risk factor for cardiovascular disease (Coutinho et al. 
1999), and one which may be more powerful than glucose concentrations determined in the fasted 
state (Leiter et al. 2005; Tominaga et al. 1999). The acute hyperglycaemic response following a sugar 
bolus is also known to transiently impair vascular endothelial function (Loader et al. 2017), and this 
is implicated in the progression of atherosclerosis and cardiovascular disease (Mah and Bruno 2012). 
Given that cardiovascular diseases are a leading cause of global mortality and morbidity (WHO 
2017), furthering our understanding of the deleterious effects of exposure to periods of 
hyperglycaemia on vascular function is a pertinent public health question.  
Two recent studies have utilised near-infrared spectroscopy (NIRS) to quantify the hyperaemic 
response in the microvasculature following limb occlusion, and demonstrated that a standard oral 
glucose tolerance test (75g of glucose) can acutely alter microvascular function in healthy young 
adults (Soares et al. 2018; Soares et al. 2017). This is conceptually important, as the earliest 
detectable changes in endothelial function associated with the metabolic syndrome may present 
within the capillary beds, rather than conduit arteries (Pinkney et al. 1997). Furthermore, post-
occlusive microvascular reactivity has been shown to be more strongly related to cardiovascular risk 
factor status (Gayda et al. 2015), and better predict future cardiovascular disease risk (Anderson et 
al. 2011), than macrovascular reactivity (flow mediated dilation; FMD) in healthy adults. However, a 
single meal rarely contains 75 g of glucose – either in isolation or in total – which means that the 
aforementioned studies (Soares et al. 2018; Soares et al. 2017) have limited real-world application. 
A major source of dietary sugar is the habitual consumption of sugar-sweetened beverages (SSB) 
(Guthrie and Morton 2000), with recent data indicating that young adults consume an average of 1.7 
servings per day (Singh et al. 2015). This translates to ~50 g of sucrose, or ~25 g of glucose with ~25 g 
of fructose (Walker et al. 2014). Given the widespread popularity of SSB, and the known association 
between SSB consumption and cardiometabolic disease (Malik et al. 2010), it is important to 
establish the vascular response to this more relevant dose. Furthermore, the metabolism of fructose 
is markedly different to glucose (Tappy et al. 2010), and the consumption of 75 g of glucose, but not 
fructose, has been shown to acutely impair FMD in healthy men (Mah et al. 2011). Currently, the 
microvascular response to a typical SSB is largely unexplored, although it has been demonstrated 
that a commercially available SSB (72g of sugar) impairs microvascular function 30 min post drink 
(Loader et al. 2017). However, the specific content of glucose and fructose was not defined in that 
study, and the time course of the postprandial changes in microvascular function following SSB 
consumption have not yet been described.  
Data are available which demonstrate that the acute vascular impairment observed following a 
glucose load is related to oxidative stress (Ceriello et al. 2002; Du et al. 1999), and that this can be 
ablated with co-ingestion of antioxidants, including vitamin C (Title et al. 2000). The vitamin C 
content of popular SSB are often advertised by manufacturers, and one third of consumers may 
actively look for “vitamin C” or “antioxidant” marketing claims when purchasing SSB (Munsell et al. 
2016). However, whilst the typical vitamin C content of popular SSB may exceed current dietary 
reference intakes (Levine et al. 1999), this is far lower than the 2000 mg previously demonstrated to 












Given the above, the purpose of this study was to observe the acute microvascular response in 
healthy young adults to 50 g of sucrose, with and without 160 mg of vitamin C, which is more 




This study was approved by the Sport and Health Sciences Ethics Committee at the University of 
Exeter (reference number 2017/M/05) and complied with the guidelines established in the 
Declaration of Helsinki. Written informed consent was obtained from all participants prior to 
commencement of the study. 
Participants 
A sample size calculation was performed a priori based upon the repeatability of the NIRS technique 
(McLay et al. 2015), and the magnitude of the change in microvascular function observed 
approximately 30 min after the consumption of a commercially available SSB (Loader et al. 2017). 
Subsequently, thirteen adults (5 female) volunteered to take part in this study (Table 1). Exclusion 
criteria included the presence of known cardiometabolic disease and the use of any medication or 
substance known to impact vascular function. Participants were familiarised to all measures prior to 
study commencement in order to minimise any potential effect of protocol anxiety on the post 
occlusive hyperaemic response (Dyson et al. 2006), and were asked to avoid strenuous exercise and 
alcohol consumption during the preceding 24 hours (Thijssen et al. 2011). Females completed all 
trials in the second week of the menstrual cycle in order to control for any potential changes in 
vascular reactivity (Williams et al. 2001). 
Experimental Protocol 
Following a ~ 10 hour overnight fast, participants reported to the laboratory at 08:00 and rested in 
the supine position for 15 min before providing a baseline capillary blood sample and measure of 
vascular function. Participants then consumed, within 10 min, one of three test drinks in a 
randomised order; 1) 300 ml of water (control; CON), 2) 300 ml of water with 50 g sucrose (SUC), or 
3) 300 ml of water with 50g sucrose and 160 mg vitamin C (VITC). The content of the test drinks 
were designed to replicate popular SSB, and the drinks were administered in a double blind fashion. 
Capillary blood samples were then collected (10, 20, 30, 60, 90 and 120 min post) post drink 
consumption. Microvascular reactivity was reassessed 30, 60, 90 and 120 min after the drink, so that 
blood flow could return to the physiological baseline (McLay et al. 2015). All procedures were 
performed in a darkened, light- and temperature-controlled (24°C) laboratory, and participants 
remained at rest between measures. 
Plasma Glucose and Lactate Concentrations 
Capillary blood samples were collected into heparin-fluoride coated Microvette CB 300 tubes and 
centrifuged immediately for 10 min at 16,000g. Plasma was then extracted from the sample and 












incremental (IAUC) area under the curve analyses for [glucose] and [lactate] were performed using 
the pre-drink (0 min) capillary sample as the baseline (GraphPad Prism, San Diego, CA). 
Microvascular reactivity 
Post-occlusive microvascular reactivity was quantified using NIRS (NIRO-300, Hamamatsu Photonics 
K. K., Japan) following 5 min of limb occlusion via rapid pneumatic cuff inflation (Hokanson, Bellevue, 
USA), as described by McClay et al. (McLay et al. 2015). This NIRS system has four laser diodes which 
emit light at different wavelengths (776, 826, 845 and 905 nm) and a black rubber probe housing 
which ensures a constant emitter-detector distance of 4 cm. The cuff was secured to the proximal 
third of the forearm, and the NIRS probe was positioned approximately 5 cm distal to the cuff at a 
reproducible point which was free from obvious tendons, veins, freckles or scars. In accordance with 
the manufacturer’s guidelines, probe was secured to the skin using a transparent sticker in order to 
negate any movement caused by cuff inflation and deflation. An opaque elastic tensor bandage was 
also loosely wrapped around the probe to further minimise any movement and block any extraneous 
light.  
The post-occlusive microvascular reactivity protocol involved 1 min of baseline measures, 5 min of 
cuff occlusion (220 mmHg) and 3 min of recovery post cuff deflation. Oxygenated (HbO2) and 
deoxygenated (HHB) haemoglobin were continuously determined throughout the protocol at a 
frequency of 1 Hz. Tissue oxygen saturation (StO2) was estimated as [HbO2]/([HbO2 + HHb]) and 
expressed as a percentage. Baseline perfusion was defined as the average StO2 during the 1 min prior 
to occlusion. Muscle oxygen consumption was derived using the StO2 slope during the first 180 s of 
occlusion (Slope 1) (Soares et al. 2019a). The rate of reperfusion (Slope 2) was calculated as the 
upslope in StO2 10 s after cuff release. When determined in this manner, Slope 2 has been shown to 
be highly correlated with established methods of arterial endothelial function (McLay et al. 2015; 
Soares et al. 2019b), and is sensitive to changes in vascular reactivity following an oral glucose 
tolerance test (Soares et al. 2017). Peak StO2 was calculated as the greatest StO2 value attained after 
cuff release and expressed as a percentage increase from baseline perfusion (peak reactive 
hyperaemia; PRH). Total reactive hyperaemia (TRH) was determined as the incremental area under 
the 3 min reperfusion curve versus time above baseline StO2 adjusted to the time taken for StO2 to 
return to pre-occlusion values. 
Statistical analyses 
Data were analysed using SPSS version 24.0 (IBM, USA) and are presented as mean ± standard 
deviation. Microvascular outcomes met the assumption of normal distribution. Analysis of 
microvascular outcomes, plasma [glucose] and [lactate] were performed using a repeated measures 
analysis of variance (ANOVA), with time and trial (CON, SUC, VITC) as the main effects. Neither the 
inclusion of sex or body mass into the ANOVA revealed a significant interaction effect for any 
outcome, so male and female data are pooled (n=13). Changes in TAUC and IAUC for plasma 
[glucose] and [lactate] were analysed using a one-way ANOVA. Homogeneity of variance was 
assessed using Mauchly’s test of sphericity, and adjusted using the Greenhouse-Geisser correction 
factor if violated. Pairwise comparisons between means were interpreted using the P value and the 
95% confidence intervals (CI), and standardized effect sizes (ES) were used to document the 
magnitude of the effect using the following thresholds: small (0.2-0.49), moderate (0.5-0.79) and 













Plasma Glucose and Lactate Concentrations 
There were no differences between trials for fasted plasma [glucose] (P=0.29). Mean plasma 
[glucose] over time are presented in Figure 1A. There was a time by trial interaction for plasma 
[glucose] (P<0.001). Plasma [glucose] was greater in SUC and VITC compared to water 10, 20 and 30 
min post drink (P<0.001 and ES>2.40 for all). Plasma [glucose] was greater 20 min post drink in VITC 
compared to SUC (P= 0.045, 95% CI 0.01 to 1.02, ES=0.49). Plasma [glucose] was not different 60 min 
post drink between VITC and CON (P=0.88, 95% CI -0.42 to 0.36, ES=0.05), but remained elevated in 
SUC compared to CON (P=0.03, 95% CI 0.10 to 1.45, ES=0.93). There were no differences in plasma 
[glucose] between trials 90 and 120 min post drink (P>0.13 for all). 
Compared to CON, TAUC-glucose was greater in SUC (P<0.001, 95% CI 95.5 to 166.4, ES=2.21) and 
VITC (P<0.001, 95% CI 78.5 to 141.6, ES=1.92), with no differences between SUC and VITC (P=0.21, 
95% CI -13.8 to 55.6, ES=0.35). Compared to CON, IAUC-glucose was greater in SUC (P=0.03, 95% CI 
39.0 to 148.3, ES=1.73) and VITC (P=0.001, 95% CI 42.5 to 138.9, ES=1.83), with no differences 
between SUC and VITC (P=0.81, 95% CI -23.4 to 29.3, ES=0.07). 
There were no differences between trials for fasted plasma [lactate] (P=0.23). Mean plasma [lactate] 
over time are presented in Figure 1B. There was a time by trial interaction for plasma [lactate] 
(P<0.001). Plasma [lactate] was greater in SUC and VITC compared to water 10, 20, 30, 40, 60 and 90 
min post drink (P<0.01 and ES>1.21 for all). Plasma [lactate] was never different between SUC and 
VITC at any time point (P>0.19 and ES<0.52 for all). 
Compared to CON, TAUC-lactate was greater in SUC (P<0.001, 95% CI 88.7 to 186.2, ES=1.94) and 
VITC (P<0.001, 95% CI 110.4 to 185.2, ES=2.75), with no differences between SUC and VITC (P=0.70, 
95% CI -66.7 to 46.1, ES=0.14). Compared to CON, IAUC-glucose was greater in SUC (P<0.001, 95% CI 
82.1 to 163.8, ES=2.59) and VITC (P<0.001, 95% CI 79.8 to 161.1, ES=2.50), with no differences 
between SUC and VITC (P=0.91, 95% CI -52.7 to 47.7, ES=0.04).  
Post-occlusive reactive hyperaemia 
Parameters of microvascular reactivity are presented in Figure 2. There was no main effect for trial 
(P=0.54), time (P=0.39) or time by trial interaction (P=0.35) for baseline StO2. A time by trial 
interaction effect was observed for the Slope 1 outcome (P<0.01). Specifically, VITC Slope 1 was 
greater than CON 30 min (P=0.001, 95% CI 0.03 to 0.07, ES=0.87) and 60 min (P=0.001, 95% CI 0.02 
to 0.05, ES=0.65) post drink. VITC Slope 1 was also greater than SUC at these time points (P=0.04, 
95% CI 0.003 to 0.08, ES=0.77, and P=0.02, 95% CI 0.01 to 0.04, ES=0.55, respectively). A small, but 
not statistically significant, difference was observed between SUC Slope 1 and CON (P=0.08, 95% CI 
0.00 to 0.04, ES=0.36) and VITC (P=0.07, 95% CI 0.00 to 0.04, ES=0.43) at 90 min. 
There was no main effect for trial (P=0.16), time (P=0.79) or time by trial interaction (P=0.55) for PRH 
(Figure 2A). There was no main effect for trial (P=0.47), time (P=0.82) or time by trial interaction 
(P=0.30) for the Slope 2 outcome (Figure 2B). There was no main effect for trial (P=0.39), time 














This is the first study to characterise the acute microvascular response to a sugar bolus which is 
reflective of a typical SSB, and also to determine whether any changes in microvascular reactivity are 
related to the vitamin C content of the drink. The key finding of this investigation is that the 
consumption of 50 g of sucrose, with or without 160 mg of vitamin C, does not influence post-
occlusive microvascular reactivity in healthy young adults.   
Presently, only two studies have characterised the Slope 2 response to a sugar load, and both 
reported an increase in the rate of reperfusion post occlusion 90 min after consumption of 75 g of 
glucose (Soares et al. 2018; Soares et al. 2017). The disparity between these findings and our own is 
likely explained by the differences in sugar moiety (sucrose; equal parts glucose and fructose) and 
quantity (50 g in total). Insulin is a potent, endothelial-dependent vasodilator (Steinberg et al. 1994) 
which increases capillary perfusion (Vincent et al. 2002), and these vasoactive responses are 
observed in the microvasculature during glucose-mediated hyperinsulinaemia (Vollenweider et al. 
1993). Although the aforementioned studies did not measure insulin, it is likely that the increase in 
the post-occlusive reperfusion rate observed 90 min post glucose consumption (Soares et al. 2018; 
Soares et al. 2017) is, at least in part, related to this mechanism. In comparison fructose is not an 
insulin secretagogue and does not increase blood flow (Vollenweider et al. 1993). Given that 25 g of 
orally administered glucose is likely to provide a far lower hyperinsulinaemic response than 75 g 
(Tillil et al. 1988), the sugar bolus adopted in our current investigation is both quantitatively and 
qualitatively different, and unique compared to existing work.   
The finding that 50 g of sucrose did not influence TRH is also of interest, as the previously observed 
impairment in this outcome (Soares et al. 2018; Soares et al. 2017) has been attributed to the 
increase in oxidative stress observed following an oral glucose challenge (Ceriello et al. 1998) and 
SSB (Loader et al. 2017). Indeed, the co-ingestion of antioxidants has been shown to protect against 
the fall in arterial reactivity (FMD) following an oral glucose tolerance test in healthy adults (Title et 
al. 2000). Whilst it is recognised that a change in hyperglycaemic redox state is not a consistent 
finding in healthy adults (Ma et al. 2005), it has also been demonstrated that only glucose, but not 
fructose, ingestion acutely increases oxidative stress and attenuates FMD in young healthy men 
(Mah et al. 2011). Thus, it is possible that the 50 g of sucrose consumed in the present study did not 
sufficiently challenge redox state in our population, although further data are required to confirm 
this. We were also not able to discern any notable microvascular benefit of the co-ingestion of 
vitamin C with sucrose. Whilst this study did not include a fourth trial to specifically isolate the effect 
of 160 mg vitamin C on microvascular reactivity, this finding is in line with other data which 
demonstrates that 500 - 1000 mg of vitamin C does not acutely influence vascular reactivity in 
healthy adults (Eskurza et al. 2004; Heitzer et al. 1996). However, we are the first to document that 
the co-ingestion of vitamin C with sucrose may alter the Slope 1 response, and this manipulation of 
metabolic rate could conceivably confer a benefit to glycaemic control. Indeed it has previously been 
observed that vitamin C may play a role in glucose disposal (Paolisso et al. 1994). Although only 
subtle differences in postprandial [glucose] were observed between the two sucrose trials at the 30 
min time point in our study, this may be related to the comparatively low glucose content (25 g) of 
these drinks. The moderate effect size observed here is an interesting finding which warrants further 













This study controlled for potential confounders of post-occlusive hyperaemia (including laboratory 
temperature, menstrual cycle, fasted state, prior exercise, time of day, protocol-anxiety and 
extraneous light (Cracowski et al. 2006; McLay et al. 2015; Thijssen et al. 2011)). Furthermore, we 
utilised a technique which is purported to be less operator dependent and more reliable than FMD 
(McLay et al. 2016) and sensitive to changes following the consumption 75 g of glucose in healthy 
adults (Soares et al. 2017). Given this methodological rigour, our data add to the extant literature 
(Soares et al. 2018; Soares et al. 2017), and collectively these data suggest that higher doses of sugar 
may be necessary for changes in postprandial microvascular reactivity, and that these changes are 
likely related to glucose, rather than fructose, consumption. However, this requires further 
investigation. 
There are many strengths to this study design, including the prescription of a test drink which better 
reflects habitual sugar exposure than the standardised oral glucose tolerance test, a double-blind 
and counterbalanced design, and the control of potential confounders which are important when 
performing vascular research. However, these data should be interpreted in light of some 
limitations. Firstly, despite following best practice (Cracowski et al. 2006; McLay et al. 2015; Thijssen 
et al. 2011), it is important to note that the present study determined microvascular function in the 
forearm, and most previous postprandial studies utilising NIRS studied changes in the tibialis 
anterior (Soares et al. 2018; Soares et al. 2017). This is relevant as the hyperaemic response 
following forearm occlusion may approximately triple that observed in the lower limb (Parker et al. 
2014; Soares et al. 2019a), which might explain the near three-fold greater Slope 2 values witnessed 
in this study compared to others (McLay et al. 2015; McLay et al. 2016; Soares et al. 2018; Soares et 
al. 2017). Furthermore, acute changes in microvascular reactivity in the lower leg may not correlate 
with changes at the forearm (Restaino et al. 2015). 
 Whilst it remains to be seen if our findings also extend to the lower limb, one recent study has 
shown that the Slope 2 outcome is altered at the forearm by a glucose challenge in healthy adults 
(Soares et al. 2019a). Whilst the NIRS device utilised by these authors differ slightly in wavelength 
and device-emitter distance, it seems unlikely that this entirely explains our findings. Indeed, the 
data presented here are of a similar order of magnitude, and we also observed a small (although not 
significant) increase in the Slope 1 response only 90 min after 50 g sucrose consumption (Soares et 
al. 2019a), which is probably reflective of only a 25 g, not 75 g, dose of glucose in the present trial. It 
is therefore plausible that this discrepancy reflects a different vascular response to the consumption 
of sucrose in our study compared to glucose (Soares et al. 2019a). However, it was beyond the scope 
of this study to include such a trial in order to make this comparison, and this remains a pertinent 
future research question.  
Secondly, whilst we detail the changes in plasma [glucose] and [lactate], it was beyond the scope of 
this study to measure [insulin] or provide insight regarding redox state. Given the pertinent nature 
of this research question, we believe that this warrants further study. However, given that we did 
not observe an impairment in microvascular reactivity following sucrose consumption, such further 
investigations should also observe whether the co-ingestion of Vitamin C can ameliorate the known 
impairment observed following 75 g of glucose consumption (Soares et al. 2019a). Finally, the 
amount of test drink consumed was not related to body mass, which ranged from 56.0 – 99.2 kg, 












reflect sugar exposure via SSB consumption and, given that no influence of weight was observed on 




A novel strength of the present study is that the test drinks reflected the sugar (25 g of glucose and 
25 g of fructose) and vitamin C (160 mg) content of commercially available, and popular (Singh et al. 
2015), SSB, rather than the typical challenge of 75 g of glucose or supraphysiological doses of 
antioxidants (Title et al. 2000) which grossly exceed current reference nutrient intakes (Levine et al. 
1999). Thus, these findings are more reflective of a real world setting, which is not offered by other 
data in this field. Collectively, our data suggest that consuming the type and amount of sugar 
typically present in SSB does not acutely influence microvascular function in ostensibly healthy 
young adults, and that the co-ingestion of vitamin C does not modulate this postprandial response. 
Further studies are warranted to replicate these findings, and to observe whether the microvascular 
response is altered in the presence of other typical behaviours (i.e. a “stacking” effect when this 
sugar load is consumed with a meal) or whether the inclusion of stimulants present in popular 




























Table 1: Participant characteristics (n=13) 
 Mean ± SD 
Age (y) 22.9 ± 1.6 
Male:Female   8:5 
Height (m)  1.73 ± 0.09 
Body mass (kg)  70.8 ± 10.8 
BMI (kg/m2)                                                    23.7 ± 8.4 
Systolic BP (mmHg)                                                     121 ± 8 
Diastolic BP (mmHg) 67 ± 7 


































Figure 1. Mean plasma [glucose] (A) and [lactate] (B) for the control (○), sugar (▲) and sugar with 
vitamin C (■) drinks. Error bars represent the standard deviation. The test drink is represented by 
the black rectangle. *P<0.05 for sugar and sugar with vitamin C compared to control; †P<0.05 for 
sugar compared to sugar and vitamin C, 
#



















Figure 2. Mean deoxygenation (Slope 1; A), reperfusion (Slope 2; B), peak reactive hyperaemia (PRH; 
C), and total reactive hyperaemia (TRH; D) for the control (○), sugar (▲) and sugar with vitamin C (■) 
drinks. Error bars represent the standard deviation. The test drink is represented by the black 
rectangle. StO2 = tissue oxygen saturation. Statistical significance between trials is denoted by * 
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